Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06069570 · ClinicalTrials.gov registry record · Phase 1
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
A Phase 1 study of Carcinoma, Non-Small-Cell Lung Cancer and Bone Metastases From Solid Tumors, sponsored by Kiromic BioPharma.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 5
- Study locations
NCT06069570 is a Phase 1 study of Carcinoma, Non-Small-Cell Lung Cancer and Bone Metastases From Solid Tumors that is actively recruiting participants, run by Kiromic BioPharma. The registered enrollment target is 48 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT06069570, a Phase 1 study of Carcinoma, Non-Small-Cell Lung Cancer and Bone Metastases From Solid Tumors, is actively recruiting participants, sponsored by Kiromic BioPharma.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally advanced or metastatic non-small cell lung cancer or solid tumors with bone metastases to evaluate the safety and efficacy of combining immunotherapy with radiation therapy.
Conditions Studied
Interventions
- BIOLOGICAL KB-GDT-01
Study Locations (5)
Arizona
- The University of Arizona Cancer Center - Tucson
California
- Beverly Hills Cancer Center - Beverly Hills
Pennsylvania
- UPMC Hillman Cancer Center - Pittsburgh
Texas
- Texas Oncology - Tyler - Tyler
Virginia
- Virginia Oncology Associates - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2026-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06069570
The ClinicalTrials.gov registry entry for NCT06069570 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kiromic BioPharma, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Carcinoma, Non-Small-Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which KB-GDT-01 is the first listed.
NCT06069570 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06069570 about?
NCT06069570 is a clinical study titled "Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases". This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally advanced or metastatic non-small cell lung cancer or solid tumors with bone metastases to evaluate the safety and efficacy of combining immunot...
What is the current status of trial NCT06069570?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2023-11-07. Estimated completion is 2026-10.
What conditions does trial NCT06069570 study?
This clinical trial studies the following conditions: Carcinoma, Non-Small-Cell Lung Cancer, Bone Metastases From Solid Tumors.
What interventions are being tested in trial NCT06069570?
The interventions under investigation include: KB-GDT-01 (BIOLOGICAL).
Who is sponsoring clinical trial NCT06069570?
This trial is sponsored by Kiromic BioPharma, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06069570 being conducted?
This trial has 5 study locations across Arizona, California, Pennsylvania, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Carcinoma, Non-Small-Cell Lung Cancer
All registered trials for this condition
Bone Metastases From Solid Tumors
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.